Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-27
1995-06-27
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514468, 549299, A61K 3136, A61K 31365
Patent
active
054280605
ABSTRACT:
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.
REFERENCES:
patent: 4486445 (1984-12-01), Patel et al.
patent: 4937373 (1990-06-01), Carson et al.
patent: 5227399 (1993-07-01), Young et al.
patent: 5252599 (1993-10-01), Girard et al.
The Merck Index, 11th ed., 5154, p. 829 (1989).
Delorme Daniel
Dube Daniel
Ducharme Yves
Fortin Rejean
Gillard John W.
Ivy C. Warren
Merck Frosst Canada Inc.
Owens A. A.
Rose David L.
Yang Mollie M.
LandOfFree
Heteroarylnaphthalene lactones as inhibitors of leukotriene bios does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroarylnaphthalene lactones as inhibitors of leukotriene bios, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroarylnaphthalene lactones as inhibitors of leukotriene bios will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-287921